The Institute of Medicine has just issued a list of the top 100 priorities for comparative effectiveness research. Among the top 25 is one of significant interest to us:
Compare the effectiveness of strategies (e.g., bio-patches, reducing central line entry, chlorhexidine for all line
entries, antibiotic impregnated catheters, treating all line entries via a sterile field) for reducing health care
associated infections (HAI), including catheter-associated bloodstream infection, ventilator associated
pneumonia, and surgical site infections in children and adults.
Just thought you would like to know that our needs are getting some attention! You can find more information at http://www.iom.edu/CMS/3809/63608/71025.aspx